The management of metastatic solid tumours has historically focused on systemic treatment
given with palliative intent. However, radical surgical treatment of oligometastases is now …

We have reviewed the studies on radiation-induced vascular changes in human and
experimental tumors reported in the last several decades. Although the reported results are …

Purpose/objectives SBRT is used to treat oligometastatic or unresectable primary abdominal
malignancies, although ablative dose delivery is limited by proximity of organs-at-risk (OAR) …

Importance Stereotactic body radiation therapy (SBRT) has become a standard treatment for
patients with medically inoperable early-stage lung cancer. However, its effectiveness in …

BACKGROUND This phase 2 multi‐institutional study was designed to determine whether
gemcitabine (GEM) with fractionated stereotactic body radiotherapy (SBRT) results in …

Task Group 101 of the AAPM has prepared this report for medical physicists, clinicians, and
therapists in order to outline the best practice guidelines for the external‐beam radiation …

Context Patients with early stage but medically inoperable lung cancer have a poor rate of
primary tumor control (30%-40%) and a high rate of mortality (3-year survival, 20%-35%) …

The burden of cancer is growing, and the disease is becoming a major economic
expenditure for all developed countries. In 2008, the worldwide cost of cancer due to …

With the recent success of checkpoint inhibitors and other immunomodulating agents, there
has been renewed interest in the combination of such agents with radiation. The biologic …

Stereotactic body radiation therapy (SBRT) is generally a tumor-ablative radiation modality
using essential technologies capable of accurately and precisely damaging the target with a …